CIK 0001937993
- Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880860746
- Phone
- +1 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- 4 Gift CEO and Chairman gave 50,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Gift CEO and Chairman gave 85,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 20,000 shares at an average $0.70 ($13,973)
- 4 Open-market buy CEO and Chairman bought 40,000 shares at an average $0.90 ($36,188)
- 4 Open-market buy CEO and Chairman bought 70,000 shares at an average $0.91 ($63,945)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 4 Open-market buy Director bought 10,000 shares at $1.39 ($13,900)
- 4 Open-market buy Director bought 20,000 shares at $1.67 ($33,398)
- 4 Grant or award CEO and Chairman acquired 25,000 shares (grant or award)
Page 3 of 4 · 69 filings